Abstract
Purpose
The aim of the study was to evaluate the effect of phosphorus-32 colloid ([32P]) intracavitary irradiation on the treatment of patients with cystic craniopharyngiomas.
Methods
Twenty patients with predominantly cystic craniopharyngiomas were admitted from 1981 to 2006. Eleven patients had [32P] intracavitary irradiation by stereotactic injection or Ommaya cyst instillation as the primary treatment, and the remaining nine had the same internal irradiation as an adjuvant treatment after tumor resection. A calculated irradiation dose of 400~500 Gy per once was delivered to the cyst wall.
Conclusion
The patients were followed up ranging from 36 to 336 months; no operative morbidity or mortality was found from [32P] intracavitary irradiation. Fourteen patients (70%) had tumor progression and required further two to four times intracavitary irradiation. All 20 cases achieved tumor shrinkage or stabilization with effective outcome 3–6 months after the last [32P] therapy. For patients with cystic craniopharyngioma, [32P] administration by stereotactic injection or Ommaya cyst instillation is a safe and helpful option, which could improve the life quality, prolong the life span, and enhance the survival rate of cystic craniopharyngioma patients.
Similar content being viewed by others
References
Karavitaki N, Cudlip S, Adams CBT, Wass JAH (2006) Craniopharyngiomas. Endo Rev 27:371–397
Dekkers OM, Biermasz NR, Smit JWA, Groot LE, Roelfsema F, Romijn JA, Pereira AM (2006) Quality of life in treated adult craniopharyngioma patients. Eur Journal of Endocrinol 154:483–489
Leksell L, Liden K (1952) 32P radiation in the treatment of craniopharyngiomas. J Neurooncol 56:69–78
Richmond IL, Wara WM, Wilson CB (1980) Role of radiation therapy in the management of craniopharyngiomas in children. Neurosurgery 6:513–517
Kobayashi T, Kageyama N, Ohara K (1981) Internal irradiation for cystic craniopharyngioma. J Neurosurg 55:896–903
Lunsford LD, Gumerman L, Levine G (1985) Stereotactic intracavitary irradiation of cystic neoplasms of the brain. Appl Neurophysiol 48:146–150
Tian Z (1997) Stereotactic intracavitary irradiation of large cystic craniopharyngiomas. J Clin Neurosci 4:161–162
Lunsford LD, Pollock BE, Kondziolka DS, Levine G, Flickinger JC (1994) Stereotactic options in the management of craniopharyngioma. Pediatr Neurosurg 21(Suppl l):90–97
Backlund E-O, Axelsson B, Bergstrand C-G, Eriksson A-L, Norén G, Ribbesjö E, Rähn T, Schnell P-O, Tallstedt L, Sääf M, Thorén M (1989) Treatment of craniopharyngiomas—the stereotactic approach in a ten to twenty three years’ perspective. Acta Neurochir (Wien) 99:11–19
Loevinger R, Tapha EM, Brownell GL (1956) Discrete radioisotope sources. 1. Beta-radiation. In: Hine GJ, Brownell GL (eds) Radiation dosimetry. Academic, New York, pp 694–754
Taasan V, Shapiro B, Taren JA, Beierwaltes WH, McKeever P, Wahl RL, Carey JE, Petry N, Mallette S (1985) Phosphorus-32 therapy of cystic grade IV astrocytomas: technique and preliminary application. J Nucl Med 26:1335–1338
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, Van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. JNCI 92:205–216
Habrand JL, Saran F, Alapetite C, Noel G, El Boustany R, Grill J (2006) Radiation therapy in the management of craniopharyngioma: current concepts and future developments. J Pediatr Endocrinol Metab 19(Suppl 1):389–394
Kalapurakal JA (2005) Radiation therapy in the management of pediatric craniopharyngiomas—a review. Childs Nerv Syst 21:808–816
Pollock BE, Lunsford LD, Kondziolka D, Levine G, Flickinger JC (1995) Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. Int J Radiat Oncol Biol Phys 33:437–446
Albright AL, Hadjipanayis CG, Lunsford LD, Kondziolka D, Pollack IF, Adelson PD (2005) Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst 21:649–654
Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD (2004) Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54:813–822
Fisher PG, Jenab J, Gopldthwaite PT, Tihan T, Wharam MD, Foer DR, Burger PC (1998) Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 14:558–563
Lyen KR, Grant DB (1982) Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57:837–841
Kumar PP, Good RR, Skultety FM, Jones EO, Chu WK (1986) Retreatment of recurrent cystic craniopharyngioma with chromic phosphorus P 32. J Natl Med Assoc 78(542–543):547–549
Sadeghi M, Moradi S, Shahzadi S, Pourbeigi H (2007) Dosimetry of (32)P radiocolloid for treatment of cystic craniopharyngioma. Appl Radiat Isot 65:519–523
Shahzadi S, Sharifi G, Andalibi R, Zali A, Ali-Asgari A (2008) Management of cystic craniopharyngiomas with intracavitary irradiation with 32P. Arch Iranian Med 11:30–34
Acknowledgments
The authors acknowledge the cooperation and assistance of Professor Weiping Liu and Professor Yi Wang, Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Rong Zhao and Jinglan Deng contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhao, R., Deng, J., Liang, X. et al. Treatment of cystic craniopharyngioma with phosphorus-32 intracavitary irradiation. Childs Nerv Syst 26, 669–674 (2010). https://doi.org/10.1007/s00381-009-1025-1
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-009-1025-1